Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Effectively tracking personal expenses is key to successful budgeting. Discover various methods to simplify your financial management.
20,024 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Big bet shifts by billionaire Michael Platt grab headlines as AI giants face moves from a prominent hedge fund. This ...
Advanced Micro Devices stock rallied more than 8% on a Wednesday as software gains lifted the tech sector. Learn what...
As Endava enters the back half of 2026, the Q3 earnings narrative centers on margin discipline, cloud-led growth, and...
A decade-long track record of dividend growth has helped Vanguard Dividend Appreciation ETF outpace many high-yield r...
Meet MIB: Vimal Kapur, Chairman and CEO of Honeywell, as we dive into his plan to split the company into three units ...
The NEOS Nasdaq-100 High Income ETF (QQQI) shows a 14% headline yield, but most of that payout is return of capital. ...
Microsoft stock hasn't been this cheap in years, offering a potential buying opportunity for patient investors. This ...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Dell Technologies stunned markets with a Q1 FY27 results beat, led by AI-optimized servers and a rising backlog. The ...
As SpaceX gears up for a public listing, investors are watching how the company plans to squeeze more profits from it...
The company behind Claude just filed for an IPO, stirring questions about AI stocks and long-term growth. This guide ...